Advertisement
Home2024-01-11T09:26:42-05:00

Top Story

HEOR

RWE

Advertisement

Featured Webinars

Handpicked Promotions & Highlights

Latest in Catalyst News powered by BioPharmCatalyst

03/18/2024 04:44 PM ET

Molecular Templates CTXR date announcement

On April 30, 2024, Citius Pharmaceuticals will announce top-line results for their recent PDUFA trial for LYMPHIR (Denileukin diftitox). The community is currently bullish on the prospects of progression, as the bulls outnumber bears by [...]

Read More
03/18/2024 04:44 PM ET

Fresh2 Group Limited PHGE date announcement

BiomX, makers of BX211, will be announcing their top-line results for the drug's recent Phase 2 trial on March 31, 2025. Currently, this drug has a 39% chance of progressing.

The announcement didn’t [...]

Read More
03/18/2024 04:44 PM ET

Molecular Templates LPTX earnings announcement

Leap Therapeutics revealed their most recent quarterly earnings data, in which EPS ended up higher than estimates. EPS was reported to be -$0.46, which beat the estimated value of -$0.55. Leap Therapeutics' EPS [...]

Read More
03/18/2024 04:44 PM ET

Tango Therapeutics TNGX earnings announcement

Tango Therapeutics revealed their most recent quarterly earnings data, in which both revenue and EPS ended up lower than estimates. Revenue, at $5.43M, was the biggest surprise for the quarter, as it missed [...]

Read More

Latest From Our Blog

Receive essential insights, resources and content direct to your inbox

Hit subscribe to stay informed!

Go to Top